{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T00:04:07Z","timestamp":1790381047495,"version":"4.1.0"},"reference-count":79,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,9,12]],"date-time":"2024-09-12T00:00:00Z","timestamp":1726099200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100005010","name":"Associazione Italiana per la Ricerca sul Cancro","doi-asserted-by":"publisher","award":["23264"],"award-info":[{"award-number":["23264"]}],"id":[{"id":"10.13039\/501100005010","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003407","name":"Ministero dell\u2019Istruzione, dell\u2019Universit\u00e0 e della Ricerca","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003407","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100021856","name":"Ministero dell'Universit\u00e0 e della Ricerca","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100021856","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy"],"published-print":{"date-parts":[[2024,11]]},"DOI":"10.1016\/j.ymthe.2024.09.011","type":"journal-article","created":{"date-parts":[[2024,9,7]],"date-time":"2024-09-07T03:27:30Z","timestamp":1725679650000},"page":"3932-3954","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"title":["Prevention of prostate cancer metastasis by a CRISPR-delivering nanoplatform for interleukin-30 genome editing"],"prefix":"10.1016","volume":"32","author":[{"given":"Cristiano","family":"Fieni","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefania Livia","family":"Ciummo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlo","family":"Sorrentino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simona","family":"Marchetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simone","family":"Vespa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paola","family":"Lanuti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lavinia Vittoria","family":"Lotti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7778-1042","authenticated-orcid":false,"given":"Emma","family":"Di Carlo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ymthe.2024.09.011_bib1","first-page":"209","article-title":"Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA. Cancer J. Clin."},{"key":"10.1016\/j.ymthe.2024.09.011_bib2","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2022.991330","article-title":"Advances and development of prostate cancer, treatment, and strategies: A systemic review","volume":"10","author":"Belkahla","year":"2022","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.ymthe.2024.09.011_bib3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s40266-018-0619-2","article-title":"Novel Cancer Therapeutics in Geriatrics: What is Unique to the Aging Patient?","volume":"36","author":"Al-Mansour","year":"2019","journal-title":"Drugs Aging"},{"key":"10.1016\/j.ymthe.2024.09.011_bib4","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1016\/j.cell.2023.03.003","article-title":"Metastasis","volume":"186","author":"Gerstberger","year":"2023","journal-title":"Cell"},{"key":"10.1016\/j.ymthe.2024.09.011_bib5","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1038\/s41698-019-0092-3","article-title":"Engineered models to parse apart the metastatic cascade","volume":"3","author":"Hapach","year":"2019","journal-title":"NPJ Precis. Oncol."},{"key":"10.1016\/j.ymthe.2024.09.011_bib6","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1038\/s41568-020-0285-7","article-title":"The immune contexture and Immunoscore in cancer prognosis and therapeutic efficacy","volume":"20","author":"Bruni","year":"2020","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.ymthe.2024.09.011_bib7","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1038\/s41568-021-00363-z","article-title":"Interleukins in cancer: from biology to therapy","volume":"21","author":"Briukhovetska","year":"2021","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.ymthe.2024.09.011_bib8","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1016\/S1074-7613(02)00324-2","article-title":"IL-27, a heterodimeric cytokine composed of EBI3 and p28 protein, induces proliferation of naive CD4(+) T\u00a0cells","volume":"16","author":"Pflanz","year":"2002","journal-title":"Immunity"},{"key":"10.1016\/j.ymthe.2024.09.011_bib9","doi-asserted-by":"crossref","first-page":"4346","DOI":"10.1074\/jbc.M112.432955","article-title":"An interleukin-6 receptor-dependent molecular switch mediates signal transduction of the IL-27 cytokine subunit p28 (IL-30) via a gp130 protein receptor homodimer","volume":"288","author":"Garbers","year":"2013","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.ymthe.2024.09.011_bib10","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1158\/1078-0432.CCR-13-2240","article-title":"Interleukin-30 expression in prostate cancer and its draining lymph nodes correlates with advanced grade and stage","volume":"20","author":"Di Meo","year":"2014","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.ymthe.2024.09.011_bib11","doi-asserted-by":"crossref","first-page":"2654","DOI":"10.1158\/0008-5472.CAN-17-3117","article-title":"Interleukin-30\/IL27p28 Shapes Prostate Cancer Stem-like Cell Behavior and Is Critical for Tumor Onset and Metastasization","volume":"78","author":"Sorrentino","year":"2018","journal-title":"Cancer Res."},{"key":"10.1016\/j.ymthe.2024.09.011_bib12","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1186\/s40425-019-0668-z","article-title":"Targeting Interleukin(IL)-30\/IL-27p28 signaling in cancer stem-like cells and host environment synergistically inhibits prostate cancer growth and improves survival","volume":"7","author":"Sorrentino","year":"2019","journal-title":"J.\u00a0Immunother. Cancer"},{"key":"10.1016\/j.ymthe.2024.09.011_bib13","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1073\/pnas.1816698116","article-title":"A folding switch regulates interleukin 27 biogenesis and secretion of its \u03b1-subunit as a cytokine","volume":"116","author":"M\u00fcller","year":"2019","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ymthe.2024.09.011_bib14","article-title":"Interleukin-30 feeds breast cancer stem cells via CXCL10 and IL23 autocrine loops and shapes immune contexture and host outcome","volume":"9","author":"Sorrentino","year":"2021","journal-title":"J.\u00a0Immunother. Cancer"},{"key":"10.1016\/j.ymthe.2024.09.011_bib15","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1186\/s13045-022-01357-6","article-title":"CRISPR\/Cas9-mediated deletion of Interleukin-30 suppresses IGF1 and CXCL5 and boosts SOCS3 reducing prostate cancer growth and mortality","volume":"15","author":"Sorrentino","year":"2022","journal-title":"J.\u00a0Hematol. Oncol."},{"key":"10.1016\/j.ymthe.2024.09.011_bib16","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1186\/s13046-023-02902-y","article-title":"Interleukin-30 subverts prostate cancer-endothelium crosstalk by fostering angiogenesis and activating immunoregulatory and oncogenic signaling pathways","volume":"42","author":"Ciummo","year":"2023","journal-title":"J.\u00a0Exp. Clin. Cancer Res."},{"key":"10.1016\/j.ymthe.2024.09.011_bib17","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1007\/s12033-023-00724-z","article-title":"An Update on the Application of CRISPR Technology in Clinical Practice","volume":"66","author":"Morshedzadeh","year":"2024","journal-title":"Mol. Biotechnol."},{"key":"10.1016\/j.ymthe.2024.09.011_bib18","doi-asserted-by":"crossref","first-page":"12267","DOI":"10.1002\/jcp.27972","article-title":"CRISPR\/Cas9 technology as a potent molecular tool for gene therapy","volume":"234","author":"Karimian","year":"2019","journal-title":"J.\u00a0Cell Physiol."},{"key":"10.1016\/j.ymthe.2024.09.011_bib19","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1038\/sj.onc.1203426","article-title":"Prostate stem cell antigen (PSCA) expression increases with high gleason score, advanced stage and bone metastasis in prostate cancer","volume":"19","author":"Gu","year":"2000","journal-title":"Oncogene"},{"key":"10.1016\/j.ymthe.2024.09.011_bib20","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1038\/s41576-022-00466-9","article-title":"Human organs-on-chips for disease modelling, drug development and personalized medicine","volume":"23","author":"Ingber","year":"2022","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.ymthe.2024.09.011_bib21","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a033688","article-title":"Metastases in Prostate Cancer","volume":"9","author":"Manna","year":"2019","journal-title":"Cold Spring Harbor Perspect. Med."},{"key":"10.1016\/j.ymthe.2024.09.011_bib22","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1073\/pnas.95.4.1735","article-title":"Prostate stem cell antigen: a cell surface marker overexpressed in prostate cancer","volume":"95","author":"Reiter","year":"1998","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ymthe.2024.09.011_bib23","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1002\/ijc.2910210305","article-title":"Isolation of a human prostate carcinoma cell line (DU 145)","volume":"21","author":"Stone","year":"1978","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.ymthe.2024.09.011_bib24","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1002\/pros.21383","article-title":"PC3 is a cell line characteristic of prostatic small cell carcinoma","volume":"71","author":"Tai","year":"2011","journal-title":"Prostate"},{"key":"10.1016\/j.ymthe.2024.09.011_bib25","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1146\/annurev-genom-083115-022258","article-title":"CRISPR\/Cas9 for Human Genome Engineering and Disease Research","volume":"17","author":"Xiong","year":"2016","journal-title":"Annu. Rev. Genomics Hum. Genet."},{"key":"10.1016\/j.ymthe.2024.09.011_bib26","doi-asserted-by":"crossref","first-page":"4317","DOI":"10.1038\/s41467-020-17863-5","article-title":"Genetically controlled membrane synthesis in liposomes","volume":"11","author":"Blanken","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ymthe.2024.09.011_bib27","series-title":"Nanomaterials Safety: Toxicity and Health Hazards","first-page":"207","article-title":"9. Toxicity and effect of nanoparticles on liver and kidneys, and kidney disorders","author":"Ghosh","year":"2019"},{"key":"10.1016\/j.ymthe.2024.09.011_bib28","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1158\/1940-6207.CAPR-10-0370","article-title":"Role of E-cadherin in antimigratory and antiinvasive efficacy of silibinin in prostate cancer cells","volume":"4","author":"Deep","year":"2011","journal-title":"Cancer Prev. Res."},{"key":"10.1016\/j.ymthe.2024.09.011_bib29","doi-asserted-by":"crossref","first-page":"2944","DOI":"10.1111\/febs.14466","article-title":"A guide to chemokines and their receptors","volume":"285","author":"Hughes","year":"2018","journal-title":"FEBS J."},{"key":"10.1016\/j.ymthe.2024.09.011_bib30","doi-asserted-by":"crossref","first-page":"379","DOI":"10.3389\/fimmu.2019.00379","article-title":"Chemokines and Chemokine Receptors: New Targets for Cancer Immunotherapy","volume":"10","author":"Mollica Poeta","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ymthe.2024.09.011_bib31","doi-asserted-by":"crossref","first-page":"2479","DOI":"10.1158\/0008-5472.CAN-07-2559","article-title":"Insulin-like growth factor-I-dependent up-regulation of ZEB1 drives epithelial-to-mesenchymal transition in human prostate cancer cells","volume":"68","author":"Graham","year":"2008","journal-title":"Cancer Res."},{"key":"10.1016\/j.ymthe.2024.09.011_bib32","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.3390\/cancers15041287","article-title":"Emerging Role of IGF-1 in Prostate Cancer: A Promising Biomarker and Therapeutic Target","volume":"15","author":"Liu","year":"2023","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.ymthe.2024.09.011_bib33","doi-asserted-by":"crossref","first-page":"2510","DOI":"10.1158\/0008-5472.CAN-20-2969","article-title":"In\u00a0Vivo Imaging of Methionine Aminopeptidase II for Prostate Cancer Risk Stratification","volume":"81","author":"Xie","year":"2021","journal-title":"Cancer Res."},{"key":"10.1016\/j.ymthe.2024.09.011_bib34","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1097\/01.MP.0000056984.62360.6C","article-title":"Prognostic significance of matrix metalloproteinase 2 and tissue inhibitor of metalloproteinase 2 expression in prostate cancer","volume":"16","author":"Ross","year":"2003","journal-title":"Mod. Pathol."},{"key":"10.1016\/j.ymthe.2024.09.011_bib35","first-page":"8511","article-title":"Significance of MMP-2 expression in prostate cancer: an immunohistochemical study","volume":"63","author":"Trudel","year":"2003","journal-title":"Cancer Res."},{"key":"10.1016\/j.ymthe.2024.09.011_bib36","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1002\/ijc.29658","article-title":"L1CAM in human cancer","volume":"138","author":"Altevogt","year":"2016","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.ymthe.2024.09.011_bib37","doi-asserted-by":"crossref","first-page":"499","DOI":"10.3390\/biom11040499","article-title":"Regulation of Cancer Metastasis by TRAIL\/Death Receptor Signaling","volume":"11","author":"Oh","year":"2021","journal-title":"Biomolecules"},{"key":"10.1016\/j.ymthe.2024.09.011_bib38","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1126\/science.7754374","article-title":"KAI1, a metastasis suppressor gene for prostate cancer on human chromosome 11p11.2","volume":"268","author":"Dong","year":"1995","journal-title":"Science"},{"key":"10.1016\/j.ymthe.2024.09.011_bib39","article-title":"Role of Metastasis Suppressor KAI1\/CD82 in Different Cancers","volume":"2021","author":"Yan","year":"2021","journal-title":"J.\u00a0Oncol."},{"key":"10.1016\/j.ymthe.2024.09.011_bib40","doi-asserted-by":"crossref","first-page":"187","DOI":"10.3389\/fendo.2017.00187","article-title":"The Role of Gonadotropin-Releasing Hormone in Cancer Cell Proliferation and Metastasis","volume":"8","author":"Gr\u00fcndker","year":"2017","journal-title":"Front. Endocrinol."},{"key":"10.1016\/j.ymthe.2024.09.011_bib41","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.semcancer.2019.07.014","article-title":"Role of heparanase in tumor progression: Molecular aspects and therapeutic options","volume":"62","author":"Masola","year":"2020","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.ymthe.2024.09.011_bib42","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.molmed.2011.01.015","article-title":"VEGF and angiopoietin signaling in tumor angiogenesis and metastasis","volume":"17","author":"Saharinen","year":"2011","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.ymthe.2024.09.011_bib43","doi-asserted-by":"crossref","first-page":"639","DOI":"10.3390\/cells10030639","article-title":"Overview on the Different Patterns of Tumor Vascularization","volume":"10","author":"Ribatti","year":"2021","journal-title":"Cells"},{"key":"10.1016\/j.ymthe.2024.09.011_bib44","doi-asserted-by":"crossref","first-page":"2095","DOI":"10.1038\/onc.2016.367","article-title":"CXCL2\/MIF-CXCR2 signaling promotes the recruitment of myeloid-derived suppressor cells and is correlated with prognosis in bladder cancer","volume":"36","author":"Zhang","year":"2017","journal-title":"Oncogene"},{"key":"10.1016\/j.ymthe.2024.09.011_bib45","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1053\/hp.2000.6698","article-title":"Metastatic patterns of prostate cancer: an autopsy study of 1,589 patients","volume":"31","author":"Bubendorf","year":"2000","journal-title":"Hum. Pathol."},{"key":"10.1016\/j.ymthe.2024.09.011_bib46","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1002\/pros.21277","article-title":"Dickkopf-1 (DKK-1) stimulated prostate cancer growth and metastasis and inhibited bone formation in osteoblastic bone metastases","volume":"71","author":"Thudi","year":"2011","journal-title":"Prostate"},{"key":"10.1016\/j.ymthe.2024.09.011_bib47","first-page":"6739","article-title":"Effects of DKK1 overexpression on bone metastasis of SBC-3 cells","volume":"15","author":"Pang","year":"2018","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.ymthe.2024.09.011_bib48","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2022.1063815","article-title":"The RANK\/RANKL\/OPG system and tumor bone metastasis: Potential mechanisms and therapeutic strategies","volume":"13","author":"Zhang","year":"2022","journal-title":"Front. Endocrinol."},{"key":"10.1016\/j.ymthe.2024.09.011_bib49","doi-asserted-by":"crossref","first-page":"788","DOI":"10.3389\/fendo.2018.00788","article-title":"Interleukin-6 Interweaves the Bone Marrow Microenvironment, Bone Loss, and Multiple Myeloma","volume":"9","author":"Harmer","year":"2018","journal-title":"Front. Endocrinol."},{"key":"10.1016\/j.ymthe.2024.09.011_bib50","doi-asserted-by":"crossref","first-page":"2544","DOI":"10.1161\/ATVBAHA.110.213751","article-title":"The Wnt antagonist Dickkopf-1 increases endothelial progenitor cell angiogenic potential","volume":"30","author":"Smadja","year":"2010","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.ymthe.2024.09.011_bib51","doi-asserted-by":"crossref","first-page":"58974","DOI":"10.18632\/oncotarget.19769","article-title":"Dickkopf-1 induces angiogenesis via VEGF receptor 2 regulation independent of the Wnt signaling pathway","volume":"8","author":"Choi","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.ymthe.2024.09.011_bib52","doi-asserted-by":"crossref","first-page":"705","DOI":"10.3390\/ijms20030705","article-title":"The Role of Osteoprotegerin and Its Ligands in Vascular Function","volume":"20","author":"Rochette","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ymthe.2024.09.011_bib53","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.critrevonc.2013.08.004","article-title":"Interleukin-6: an angiogenic target in solid tumours","volume":"89","author":"Middleton","year":"2014","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"10.1016\/j.ymthe.2024.09.011_bib54","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1038\/s41591-020-01195-4","article-title":"Targeting metastatic cancer","volume":"27","author":"Ganesh","year":"2021","journal-title":"Nat. Med."},{"key":"10.1016\/j.ymthe.2024.09.011_bib55","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1002\/1878-0261.12024","article-title":"Understanding the molecular mechanisms driving metastasis","volume":"11","author":"Massagu\u00e9","year":"2017","journal-title":"Mol. Oncol."},{"key":"10.1016\/j.ymthe.2024.09.011_bib56","doi-asserted-by":"crossref","first-page":"870","DOI":"10.3390\/bios12100870","article-title":"Application of Microfluidics in Drug Development from Traditional Medicine","volume":"12","author":"Li","year":"2022","journal-title":"Biosensors"},{"key":"10.1016\/j.ymthe.2024.09.011_bib57","doi-asserted-by":"crossref","first-page":"2591","DOI":"10.1158\/1078-0432.CCR-04-1842","article-title":"Prostate stem cell antigen is overexpressed in prostate cancer metastases","volume":"11","author":"Lam","year":"2005","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.ymthe.2024.09.011_bib60","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1186\/s13578-023-01159-4","article-title":"Modulation of cell cycle increases CRISPR-mediated homology-directed DNA repair","volume":"13","author":"Li","year":"2023","journal-title":"Cell Biosci."},{"key":"10.1016\/j.ymthe.2024.09.011_bib61","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abc9450","article-title":"CRISPR-Cas9 genome editing using targeted lipid nanoparticles for cancer therapy","volume":"6","author":"Rosenblum","year":"2020","journal-title":"Sci. Adv."},{"key":"10.1016\/j.ymthe.2024.09.011_bib62","doi-asserted-by":"crossref","first-page":"2085","DOI":"10.1038\/s12276-023-01086-x","article-title":"Immunogenicity of lipid nanoparticles and its impact on the efficacy of mRNA vaccines and therapeutics","volume":"55","author":"Lee","year":"2023","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.ymthe.2024.09.011_bib63","doi-asserted-by":"crossref","first-page":"a038026","DOI":"10.1101\/cshperspect.a038026","article-title":"Myeloid Cells in Metastasis","volume":"10","author":"Swierczak","year":"2020","journal-title":"Cold Spring Harbor Perspect. Med."},{"key":"10.1016\/j.ymthe.2024.09.011_bib64","article-title":"Tumor angiogenesis: Current challenges and therapeutic opportunities","volume":"28","author":"Al-Ostoot","year":"2021","journal-title":"Cancer Treat. Res. Commun."},{"key":"10.1016\/j.ymthe.2024.09.011_bib65","doi-asserted-by":"crossref","first-page":"140","DOI":"10.3390\/organoids2030011","article-title":"Incorporating Immune Cells into Organoid Models: Essential for Studying Human Disease","volume":"2","author":"Bogoslowski","year":"2023","journal-title":"Organoids"},{"key":"10.1016\/j.ymthe.2024.09.011_bib66","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1189\/jlb.5VMR1116-491RR","article-title":"Myeloid-derived cells in prostate cancer progression: phenotype and prospective therapies","volume":"102","author":"Lopez-Bujanda","year":"2017","journal-title":"J.\u00a0Leukoc. Biol."},{"key":"10.1016\/j.ymthe.2024.09.011_bib67","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1038\/s41586-022-04522-6","article-title":"Androgen receptor activity in T\u00a0cells limits checkpoint blockade efficacy","volume":"606","author":"Guan","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.ymthe.2024.09.011_bib68","doi-asserted-by":"crossref","first-page":"S42","DOI":"10.1038\/d41586-022-02861-y","article-title":"Could immunotherapy finally break through in prostate cancer?","volume":"609","author":"King","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.ymthe.2024.09.011_bib69","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1126\/science.aat5011","article-title":"CRISPR-Cas guides the future of genetic engineering","volume":"361","author":"Knott","year":"2018","journal-title":"Science"},{"key":"10.1016\/j.ymthe.2024.09.011_bib70","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.semcdb.2019.04.018","article-title":"CRISPR-Cas9: A multifaceted therapeutic strategy for cancer treatment","volume":"96","author":"Kaushik","year":"2019","journal-title":"Semin. Cell Dev. Biol."},{"key":"10.1016\/j.ymthe.2024.09.011_bib72","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1038\/s41467-018-03408-4","article-title":"Expansion of functional personalized cells with specific transgene combinations","volume":"9","author":"Lipps","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ymthe.2024.09.011_bib73","first-page":"251","article-title":"Human alveolar epithelial cells expressing tight junctions to model the air-blood barrier","volume":"33","author":"Kuehn","year":"2016","journal-title":"ALTEX"},{"key":"10.1016\/j.ymthe.2024.09.011_bib74","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1002\/term.2507","article-title":"Bone marrow-on-a-chip: Long-term culture of human haematopoietic stem cells in a three-dimensional microfluidic environment","volume":"12","author":"Sieber","year":"2018","journal-title":"J.\u00a0Tissue Eng. Regen. Med."},{"key":"10.1016\/j.ymthe.2024.09.011_bib75","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1093\/nar\/gkn1003","article-title":"Structural analysis of DNA complexation with cationic lipids","volume":"37","author":"Marty","year":"2009","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.ymthe.2024.09.011_bib76","doi-asserted-by":"crossref","first-page":"12029","DOI":"10.1002\/anie.201506030","article-title":"Self-assembled DNA nanoclews for the efficient delivery of CRISPR-Cas9 for genome editing","volume":"54","author":"Sun","year":"2015","journal-title":"Angew. Chem. Int. Ed. Engl."},{"key":"10.1016\/j.ymthe.2024.09.011_bib77","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1021\/acs.langmuir.6b04304","article-title":"Fusogenic Liposomes as Nanocarriers for the Delivery of Intracellular Proteins","volume":"33","author":"Kube","year":"2017","journal-title":"Langmuir"},{"key":"10.1016\/j.ymthe.2024.09.011_bib78","first-page":"297","article-title":"Stealth liposomes: review of the basic science, rationale, and clinical applications, existing and potential","volume":"1","author":"Immordino","year":"2006","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.ymthe.2024.09.011_bib79","first-page":"7190","article-title":"Internalizing antibodies are necessary for improved therapeutic efficacy of antibody-targeted liposomal drugs","volume":"62","author":"Sapra","year":"2002","journal-title":"Cancer Res."},{"key":"10.1016\/j.ymthe.2024.09.011_bib80","doi-asserted-by":"crossref","first-page":"21733","DOI":"10.1039\/C9NR09347H","article-title":"On the role of helper lipids in lipid nanoparticle formulations of siRNA","volume":"11","author":"Kulkarni","year":"2019","journal-title":"Nanoscale"},{"key":"10.1016\/j.ymthe.2024.09.011_bib81","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1164\/rccm.200903-0400OC","article-title":"Expression of IL-32 in human lung cancer is related to the histotype and metastatic phenotype","volume":"180","author":"Sorrentino","year":"2009","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.ymthe.2024.09.011_bib82","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1038\/s41596-020-00437-6","article-title":"Reliable detection of somatic mutations in solid tissues by laser-capture microdissection and low-input DNA sequencing","volume":"16","author":"Ellis","year":"2021","journal-title":"Nat. Protoc."}],"container-title":["Molecular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001624005963?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001624005963?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T19:29:59Z","timestamp":1783020599000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525001624005963"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11]]},"references-count":79,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2024,11]]}},"alternative-id":["S1525001624005963"],"URL":"https:\/\/doi.org\/10.1016\/j.ymthe.2024.09.011","relation":{},"ISSN":["1525-0016"],"issn-type":[{"value":"1525-0016","type":"print"}],"subject":[],"published":{"date-parts":[[2024,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prevention of prostate cancer metastasis by a CRISPR-delivering nanoplatform for interleukin-30 genome editing","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymthe.2024.09.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier Inc. on behalf of The American Society of Gene and Cell Therapy.","name":"copyright","label":"Copyright"}]}}